Anti-depressant bupropion may alleviate negative mood associated with quitting smoking

A NIDA-funded study at the University of Pennsylvania Transdisciplinary Tobacco Use Research Center has found that the anti-depressant bupropion may help people stop smoking by alleviating negative moods, such as depression and despair, often experienced during nicotine withdrawal. This is the first study to find that such psychological changes may contribute to bupropion's effects on smoking cessation outcomes in a clinical setting.

Dr. Caryn Lerman of the Abramson Cancer Center of the University of Pennsylvania led the research team that examined 251 male and female smokers ages 18 and older. Participants were randomly assigned to receive 10 weeks of treatment with bupropion or a placebo, plus behavioral counseling. Bupropion was initiated on the day of the first counseling session, two weeks before the target quit date. Counseling included nicotine fading (slowly decreasing nicotine intake), coping with cues that trigger smoking, stress management, and relapse prevention. During treatment, participants regularly completed questionnaires about their withdrawal symptoms and positive and negative feelings.

At the end of treatment, 48 percent of bupropion participants were abstinent from smoking, versus 29 percent of those receiving the placebo. The bupropion group exhibited a decrease in negative mood, while those receiving placebo showed an increase in negative mood. Although bupropion reduced the severity of the symptoms of withdrawal, negative mood was more strongly related to smoking relapse.

WHAT IT MEANS: Bupropion may be beneficial for smokers who experience negative moods and who smoke, in part, to manage these symptoms.


Contact: Blair Gately
NIH/National Institute on Drug Abuse

Page: 1

Related medicine news :

1. Anti-depressants used during pregnancy linked to neonatal withdrawal syndrome
2. Study finds bupropion may be effective smoking cessation aid for women
3. Immersion in virtual world alleviates pain from injury
4. Kadian alleviated chronic pain in patients unsuccessfully treated with well-known therapies
5. Climara Pro (TM) helps alleviate menopausal hot flashes and night sweats
6. Mayo Clinic study shows melatonin helps alleviate violent sleep disorder symptoms
7. Yale researchers create topical estrogen that alleviates sexual dysfunction in menopausal women and eliminates side effects of conventional estrogen
8. Antidepressant drug alleviates hot flashes in men undergoing prostate cancer treatment
9. Anger, negative emotions may trigger stroke
10. Re-analysis of large trials shows greatest benefit of chemotherapy in ER-negative tumors
11. Acute decrease in testosterone level has few negative effects on healthy men

Post Your Comments:

(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a ... sleep tracking systems. The new app features a more intuitive SleepScore™ that rates sleep ... well you slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes the ...
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, ... from Bronx, N.Y. “I thought there had to be a convenient and comfortable way ... , The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. ...
(Date:11/25/2015)... Md (PRWEB) , ... November 25, 2015 , ... ... Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for ... of this disease. The Periwinkle Pioneers, nominated by the public, will receive special ...
(Date:11/25/2015)... ... November 25, 2015 , ... An unlikely ... resulting in a way for homeless people to have a more dignified and ... new initiative whereby they are repurposing plastic bags into sleeping mats for the ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... on providing comprehensive solutions involving adult stem cell therapies to patients with chronic ... the “Regenestem” name as a Registered Trademark (RTM). , Organizations are required to ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 Allergan plc ... company, and Rugen Therapeutics, a start-up  biotechnology company ... unmet CNS disorders and funded by the F-Prime ... have entered into an exclusive collaboration to support ... Autism Spectrum Disorders (ASD) and Obsessive Compulsive disorders ...
(Date:11/25/2015)... NEW YORK , November 25, 2015 ... global market of self-monitoring blood glucose devices was valued ... to grow with a CAGR of 5.7% during 2015 ... increasing geriatric population and increasing prevalence of diabetes. In ... about diabetes care is also contributing to the growth ...
(Date:11/25/2015)... November 25, 2015 Developmental, commercial, ... boosting the profitability of pharmaceutical products, says GBI ... and regulatory/legal strategies all play a key role ... GBI Research . --> Developmental, ... key role in boosting the profitability of pharmaceutical products, ...
Breaking Medicine Technology:
Cached News: